alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › exon

exon

4 studies tagged exon, dated 2000-09-01 to 2023-03-22. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. ASO targeting RBM3 temperature-controlled poison exon splicing prevents neurodegeneration in vivo 2023-03-22
  2. Identification of regulatory cis-acting elements for alternative splicing of presenilin 2 exon 5 under hypoxic stress conditions 2004-12-01
  3. Presenilin-1 mutation L271V results in altered exon 8 splicing and Alzheimer's disease with non-cored plaques and no neuritic dystrophy 2002-12-19

Studies

4 studies carry this tag.

Date range

2000 to 2023

Top journals

  • Acta neuropathologica 1
  • EMBO molecular medicine 1
  • Journal of neurochemistry 1
  • The Journal of biological chemistry 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. ASO targeting RBM3 temperature-controlled poison exon splicing prevents neurodegeneration in vivo

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. EMBO molecular medicine 2023-03-22 Drug development

    Neurodegenerative diseases are increasingly prevalent in the aging population, yet no disease-modifying treatments are currently available.

  2. Identification of regulatory cis-acting elements for alternative splicing of presenilin 2 exon 5 under hypoxic stress conditions

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neurochemistry 2004-12-01 Drug development

    An alternatively spliced form of the presenilin 2 (PS2) gene lacking exon 5 (PS2V) was found in human brains with sporadic Alzheimer's disease.

  3. Presenilin-1 mutation L271V results in altered exon 8 splicing and Alzheimer's disease with non-cored plaques and no neuritic dystrophy

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. The Journal of biological chemistry 2002-12-19 Drug development

    The mutation L271V in exon 8 of the presenilin-1 (PS-1) gene was detected in an Alzheimer's disease pedigree.

  4. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Acta neuropathologica 2000-09-01 Drug development

    Neurofibrillary tangles (NFT), one of the histopathological hallmarks of Alzheimer's disease (AD) and progressive supranuclear palsy (PSP), and Pick bodies in Pick's disease (PiD) are composed of microtubule-associated protein tau, which is the product of alternative splicing of a gene on chromosome 17.

All topic tags with their study counts